ArticleOncoTargets and therapy2019

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients.

Yu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.